HEMATOPOIETIC STEM- AND PROGENITOR-CELL GENE THERAPY FOR HURLER SYNDROME

Abstract

Allogeneic hematopoietic stem-cell transplantation is the standard of care for
Hurler syndrome (mucopolysaccharidosis type I, Hurler variant [MPSIH]). However,
this treatment is only partially curative and is associated with complications.